Clinical advances of RNA therapeutics for treatment of neurological and neuromuscular diseases

RNA therapeutics comprise a diverse group of oligonucleotide-based drugs such as antisense oligonucleotides (ASOs), small interfering RNAs (siRNAs), and short hairpin RNAs (shRNAs) that can be designed to selectively interact with drug targets currently undruggable with small molecule-based drugs or...

Descripción completa

Detalles Bibliográficos
Autores principales: Holm, Anja, Hansen, Stine N., Klitgaard, Henrik, Kauppinen, Sakari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067473/
https://www.ncbi.nlm.nih.gov/pubmed/35482908
http://dx.doi.org/10.1080/15476286.2022.2066334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067473/
https://www.ncbi.nlm.nih.gov/pubmed/35482908
http://dx.doi.org/10.1080/15476286.2022.2066334

Ejemplares similares